Skip to content

PRoMOTE Follow-up Observational Study

Patient Risk Triage in ICD Remote Follow-up Observational Study (PRoMOTE FU)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03009175
Acronym
PRoMOTE FU
Enrollment
287
Registered
2017-01-04
Start date
2013-06-30
Completion date
2014-08-31
Last updated
2025-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of the study is: * To evaluate the Heart Failure Risk Status (HFRS) feature performance. * To establish the feasibility of remote follow-up in which patient risk triaging is performed by nurse-led review of HFRS feature as supplemental information.

Interventions

DEVICEImplantable Cardiac Defibrillator, Cardiac Resynchronization Therapy Defibrillator/Pacemaker

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Patients that meet all of following criteria could be included in the study: * Implant of a commercially available Medtronic CRTD or ICD device with or without the Optivol Fluid Status Monitoring feature. * Inclusion in the Medtronic Carelink Network. * Local consent available for CL network as well as general local consent available for the use of data in observational studies signed and informative sheet delivered.

Exclusion criteria

* Patients under the age of 18 years.

Design outcomes

Primary

MeasureTime frame
Clinical Data collected through the phone call to the patients during the 6 months of study duration will be correlated to the HF risk classification provided by the HFRS feature on each transmission.6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026